Literature DB >> 25861526

Two cases of advanced gastric carcinoma mimicking a malignant gastrointestinal stromal tumor.

Ha Song Shin1, Sung Jin Oh1, Byoung Jo Suh1.   

Abstract

Gastric cancer that mimics a submucosal tumor is rare. This rarity and the normal mucosa covering the protuberant tumor make it difficult to diagnosis with endoscopy. We report two cases of advanced gastric cancer that mimicked malignant gastrointestinal stromal tumors preoperatively. In both cases, the possibility of cancer was not completely ruled out. In the first case, a large tumor was suspected to be cancerous during surgery. Therefore, total gastrectomy with lymph node dissection was performed. In the second case, the first gross endoscopic finding was of a Borrmann type II advanced gastric cancer-like protruding mass with two ulcerous lesions invading the anterior wall of the body. Therefore, subtotal gastrectomy with lymph node dissection was performed. Consequently, delayed treatment of cancer was avoided in both cases. If differential diagnosis between malignant gastrointestinal stromal tumor and cancer is uncertain, a surgical approach should be carefully considered due to the possible risk of adenocarcinoma.

Entities:  

Keywords:  Gastrointestinal stromal tumors; Stomach neoplasms

Year:  2015        PMID: 25861526      PMCID: PMC4389100          DOI: 10.5230/jgc.2015.15.1.68

Source DB:  PubMed          Journal:  J Gastric Cancer        ISSN: 1598-1320            Impact factor:   3.720


  10 in total

1.  Surgical treatment of GIST--an institutional experience of a high-volume center.

Authors:  Katrin Schwameis; Alexandra Fochtmann; Michael Schwameis; Reza Asari; Sophie Schur; Wolfgang Köstler; Peter Birner; Ahmed Ba-Ssalamah; Johannes Zacherl; Fritz Wrba; Thomas Brodowicz; Sebastian Friedrich Schoppmann
Journal:  Int J Surg       Date:  2013-08-30       Impact factor: 6.071

2.  Laparoscopic transgastric tumor-everting resection of the gastric submucosal tumor located near the esophagogastric junction.

Authors:  Nobuhiro Morinaga; Akihiko Sano; Kazuhisa Katayama; Kazuya Suzuki; Koji Kamisaka; Takayuki Asao; Hiroyuki Kuwano
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2004-12       Impact factor: 1.719

3.  Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour.

Authors:  P Hohenberger; U Ronellenfitsch; O Oladeji; D Pink; P Ströbel; E Wardelmann; P Reichardt
Journal:  Br J Surg       Date:  2010-08-20       Impact factor: 6.939

4.  Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor.

Authors:  M C Heinrich; D J Griffith; B J Druker; C L Wait; K A Ott; A J Zigler
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

5.  Gastric carcinoma resembling submucosal tumor.

Authors:  Yasuhiko Umehara; Taizo Kimura; Tadatoshi Okubo; Yoshihiko Sano; Katsuhiko Nakai; Satoshi Oi; Yukihiro Higashi; Kazuhito Funai
Journal:  Gastric Cancer       Date:  1999-11       Impact factor: 7.370

Review 6.  Treatment of gastric cancer.

Authors:  Michele Orditura; Gennaro Galizia; Vincenzo Sforza; Valentina Gambardella; Alessio Fabozzi; Maria Maddalena Laterza; Francesca Andreozzi; Jole Ventriglia; Beatrice Savastano; Andrea Mabilia; Eva Lieto; Fortunato Ciardiello; Ferdinando De Vita
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

7.  Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging.

Authors:  E H Ng; R E Pollock; M F Munsell; E N Atkinson; M M Romsdahl
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

8.  Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.

Authors:  Burton L Eisenberg; Jonathan Harris; Charles D Blanke; George D Demetri; Michael C Heinrich; James C Watson; John P Hoffman; Scott Okuno; John M Kane; Margaret von Mehren
Journal:  J Surg Oncol       Date:  2009-01-01       Impact factor: 3.454

9.  Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread.

Authors:  Guy J C Burkill; Mohammed Badran; Omar Al-Muderis; J Meirion Thomas; Ian R Judson; Cyril Fisher; Eleanor C Moskovic
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

10.  Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade.

Authors:  Tadashi Hasegawa; Yoshihiro Matsuno; Tadakazu Shimoda; Setsuo Hirohashi
Journal:  Hum Pathol       Date:  2002-06       Impact factor: 3.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.